By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today reported a 33 percent increase year over year in revenues for the second quarter with its Scientific Instruments division also growing 33 percent.

For the three months ended June 30, the company posted $401.2 million in revenues, up from $300.9 million a year ago, surpassing analysts' forecasts of $384.1 million. The firm said that on a currency-adjusted basis, revenues grew 21 percent year over year, corresponding to organic growth of 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.